SGLT2 Inhibitors and Diabetes Management

Dear Dr. Renukaprasad A R, Sodium-glucose co-transporter 2 inhibitors block the glucose absorption in the renal proximal tubule, an insulin-independent mechanism that contributes to a critical role in glycemic regulation. These inhibitors prevent both renal damage and the onset of chronic kidney disease and cardiovascular events. Join the eminent Endocrinologist, Dr. Ihab El Tayeb, in an exclusive session, where he will discuss "Cardiorenal Protection with SGLT2 Inhibitors in Diabetes," TODAY, 3:00 PM IST onwards. Session highlights - Mechanism of SGLT2 inhibitors Contraindications of SGLT2 inhibitors The role of SGLT2 in the management of diabetes Join Now Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*